Finally: Common Drug Improves COVID-19 Survival in Trial

(MedPage Today) -- Dexamethasone, the familiar glucocorticoid, reduced deaths in hospitalized COVID-19 patients with severe disease by one-third compared to those receiving usual care, according to topline interim results from the RECOVERY trial...